METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
France
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
Spain
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
Germany
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
Switzerland
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
Belgium
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
METHOD OF PREVENTING OR TREATING DISEASE CHARACTERIZED BY NEOPLASTIC CELLS EXPRESSING CD40
Austria
95906686.1
Filed on 1994-12-21
95906686.1
Filed on 1994-12-21
A Semiconductor For Measuring Biological Interactions
US Patent 8,614,466
Filed on 2011-05-11
Filed on 2011-05-11
A Semiconductor For Measuring Biological Interactions
European Patent
09828144.7
Filed on 2009-11-18
09828144.7
Filed on 2009-11-18
Gene Signature for Predicting Prognosis Of Patients With Solid Tumors
US Patent 8,735,082
Filed on 2011-05-04
Filed on 2011-05-04
GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS
European Patent
09752261.9
Filed on 2009-11-10
09752261.9
Filed on 2009-11-10